Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.

Wademan, DT; Busakwe, L; Nicholson, TJ; van der Zalm, M; Palmer, M; Workman, J; Turkova, A; Crook, AM; Thomason, J; Gibb, DM; +3 more... Seeley, J; Hesseling, A; Hoddinott, G; (2019) Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 23 (12). pp. 1263-1268. ISSN 1027-3719 DOI: https://doi.org/10.5588/ijtld.19.0115

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.5588/ijtld.19.0115

Abstract

Item Type Article
Faculty and Department Faculty of Public Health and Policy > Dept of Global Health and Development
PubMed ID 31931909
Elements ID 142265

Share

Download

Filename: s7.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar